Loading clinical trials...
Loading clinical trials...
Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies
Conditions
Interventions
CliniMACS Fractionation system (Arm A)
CliniMACS Fractionation system (Arm B)
+1 more
Locations
1
United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Start Date
September 5, 2012
Primary Completion Date
January 8, 2021
Completion Date
January 8, 2021
Last Updated
August 5, 2022
NCT04570423
NCT06303193
NCT06735690
NCT07249528
NCT05564390
NCT00131014
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions